MarketBeat listed Regeneron Pharmaceuticals, AbbVie, and Moderna as stocks to watch on October 31, 2026.

The entities involved

• Regeneron Pharmaceuticals →

  American pharmaceutical company

  • Morgan Stanley dropped price target and Cantor Fitzgerald reduced price target on Regeneron Pharmaceuticals stock.Mon 17:01
  • Regeneron, the FDA, and research institutions are advancing the Ebola response in the DRC through drug approvals and clinical trials.Mon 05:37
• Moderna →

  American biotechnology company

  • Moderna is advancing vaccine trials in the Democratic Republic of the Congo.Wed 19:27
  • Getty Images provided the image source for an article involving Moderna.Mon 10:11
• AbbVie →

  pharmaceutical company

  • AbbVie announced a joint development partnership with IGI, led by Lida Pacaud.Wed 17:17
  • Medicare eligibility rules affect AbbVie drug pricing, while the FDA regulates Creon's classification and approval for Medicare beneficiaries.Wed 16:42

Related events

• MarketBeat listed Johnson & Johnson, AbbVie, Pfizer, Merck KGaA, Eli Lilly, Gilead Sciences, and Novartis as stocks to watch.Oct 24
• Moderna's stock gains are being driven by FDA approval and the broader growth of AI businesses, as a Nasdaq constituent.Oct 17
• Moderna, Pfizer, and Merck are part of a healthcare rotation story, with Moderna outperforming Pfizer in current stock gains.Oct 15